RxDoctor Payments Data

Linda Martinez

Adult Medicine · Doral, FLNPI 1821411745

Payments from drug & device makers

What this record shows

Every reported general payment came from a single manufacturer, Novartis.

$543in general payments, 2019–2025

Across 4 payments — averaging $135.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$543
$2,111,205in research payments, 2019–2025

Across 213 payments — averaging $9911.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$829K
  • UCB SA$562K
  • Taro Pharmaceuticals USA, Inc.$360K
  • Intercept Pharmaceuticals, Inc.$196K
  • Royal Biologics, Inc.$54K
  • Intercept Pharma Europe Ltd.$43K
  • plus $67K from 5 others

What the payments were for

  • Travel & lodging$28753%
  • Food & beverage$25747%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis4$543

How this compares

$543 in reported general payments places this provider in the 55th percentile of 195 adult medicine providers in Florida.

See all adult medicine providers in Florida

Other adult medicine in Doral

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →